SARS-CoV-2 spike protein-mediated cardiomyocyte fusion may contribute to increased arrhythmic risk in COVID-19
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0282151 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Daniel J Clemens und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Pharmacology & Experimental Therapeutics, Windland Smith Rice Sudden Death Genomics Laboratory, Mayo Clinic, Rochester, MN, U…. Hauptthemen laut MEDLINE: Long QT Syndrome, Induced Pluripotent Stem Cells, COVID-19. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Mayo Clinic.
Abstract (Originalsprache)
Background
SARS-CoV-2-mediated COVID-19 may cause sudden cardiac death (SCD). Factors contributing to this increased risk of potentially fatal arrhythmias include thrombosis, exaggerated immune response, and treatment with QT-prolonging drugs. However, the intrinsic arrhythmic potential of direct SARS-CoV-2 infection of the heart remains unknown.
Objective
To assess the cellular and electrophysiological effects of direct SARS-CoV-2 infection of the heart using human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs). Methods hiPSC-CMs were transfected with recombinant SARS-CoV-2 spike protein (CoV-2 S) or CoV-2 S fused to a modified Emerald fluorescence protein (CoV-2 S-mEm). Cell morphology was visualized using immunofluorescence microscopy. Action potential duration (APD) and cellular arrhythmias were measured by whole cell patch-clamp. Calcium handling was assessed using the Fluo-4 Ca 2+ indicator.
Results
Transfection of hiPSC-CMs with CoV-2 S-mEm produced multinucleated giant cells (syncytia) displaying increased cellular capacitance (75±7 pF, n = 10 vs. 26±3 pF, n = 10; P
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Molecular Pharmacology & Experimental Therapeutics, Windland Smith Rice Sudden Death Genomics Laboratory, Mayo Clinic, Rochester, MN, United States of America.
- Division of Heart Rhythm Services, Department of Cardiovascular Medicine, Windland Smith Rice Genetic Heart Rhythm Clinic, Mayo Clinic, Rochester, MN, United States of America.
- Discovery Engine/Program for Hypoplastic Left Heart Syndrome, Mayo Clinic, Rochester, MN, United States of America.
- Department of Molecular Medicine, Mayo Clinic, Rochester, MN, United States of America.
- Wanek Family Program for HLHS-Stem Cell Pipeline, Mayo Clinic, Rochester, MN, United States of America.
- Division of Pediatric Cardiology, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, MN, United States of America.
ORCID-Profile: Roberto Cattaneo
Förderung
- Mayo Clinic
Zitieren
APA
Clemens, D. J., Ye, D., Zhou, W., Kim, C. S. J., Pease, D. R., Navaratnarajah, C. K., Barkhymer, A., Tester, D. J., Nelson, T. J., Cattaneo, R., Schneider, J. W., & Ackerman, M. J. (2023). SARS-CoV-2 spike protein-mediated cardiomyocyte fusion may contribute to increased arrhythmic risk in COVID-19. PLOS ONE. https://doi.org/10.1371/journal.pone.0282151
Vancouver
Clemens DJ, Ye D, Zhou W, Kim CSJ, Pease DR, Navaratnarajah CK, et al. SARS-CoV-2 spike protein-mediated cardiomyocyte fusion may contribute to increased arrhythmic risk in COVID-19. PLOS ONE. 2023. doi:10.1371/journal.pone.0282151
BibTeX
@article{Clemens2023,
author = {Clemens, Daniel J and Ye, Dan and Zhou, Wei and Kim, C S John and Pease, David R and Navaratnarajah, Chanakha K and Barkhymer, Alison and Tester, David J and Nelson, Timothy J and Cattaneo, Roberto and Schneider, Jay W and Ackerman, Michael J},
title = {SARS-CoV-2 spike protein-mediated cardiomyocyte fusion may contribute to increased arrhythmic risk in COVID-19},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0282151}
}
EUVIMED